142 related articles for article (PubMed ID: 221552)
1. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives.
Harris DN; Asaad MM; Phillips MB; Goldenberg HJ; Antonaccio MJ
J Cyclic Nucleotide Res; 1979; 5(2):125-34. PubMed ID: 221552
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
4. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor.
Bertelé V; Falanga A; Tomasiak M; Cerletti C; de Gaetano G
Thromb Haemost; 1984 Feb; 51(1):125-8. PubMed ID: 6326343
[TBL] [Abstract][Full Text] [Related]
5. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
6. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
Ashida SI; Abiko Y
Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
[TBL] [Abstract][Full Text] [Related]
7. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
Watanabe Y; Jakobs KH
Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the functional responses of human neutrophils occur independently of transient elevations in cyclic AMP levels.
Simchowitz L; Spilberg I; Atkinson JP
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(1):35-47. PubMed ID: 6315792
[TBL] [Abstract][Full Text] [Related]
10. Lithium inhibits adenylate cyclase of human platelets.
Imandt L; Tijhuis D; Wessels H; Haanen C
Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
[TBL] [Abstract][Full Text] [Related]
11. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
Kaiya H; Ofuji M; Nozaki M; Tsurumi K
Psychopharmacol Bull; 1990; 26(3):381-4. PubMed ID: 2177206
[TBL] [Abstract][Full Text] [Related]
12. Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets.
Walter F; Vulliemoz Y; Verosky Y; Triner L
Anesth Analg; 1980 Nov; 59(11):856-61. PubMed ID: 6252800
[TBL] [Abstract][Full Text] [Related]
13. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
Salzman EW; Levine L
J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
[TBL] [Abstract][Full Text] [Related]
14. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
Defreyn G; Gachet C; Savi P; Driot F; Cazenave JP; Maffrand JP
Thromb Haemost; 1991 Feb; 65(2):186-90. PubMed ID: 2053105
[TBL] [Abstract][Full Text] [Related]
15. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
Gresele P; Blockmans D; Deckmyn H; Vermylen J
J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
[TBL] [Abstract][Full Text] [Related]
16. Heparin inhibits PGE1-sensitive adenylate cyclase and antagonizes PGE1 antiaggregating effect in human platelets.
Reches A; Eldor A; Salomon Y
J Lab Clin Med; 1979 Apr; 93(4):638-44. PubMed ID: 429861
[TBL] [Abstract][Full Text] [Related]
17. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
Hashimoto S; Itoh Y; Kawaguchi A; Mizuno Y; Muraoka M; Tsuchiya M
J Cell Physiol; 1987 Dec; 133(3):499-506. PubMed ID: 2826498
[TBL] [Abstract][Full Text] [Related]
19. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets.
Macfarlane DE; Mills DC
J Cyclic Nucleotide Res; 1981; 7(1):1-11. PubMed ID: 6265510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
